The agricultural biotechnology developer had raised $101m from investors including chemical producer BASF.
Arcadia Biosciences, a US-based agricultural biotechnology company backed by chemical producer BASF, filed for an initial public offering yesterday and is aiming to raise $86.3m.
Arcadia develops agriculture-based technology that helps crops grow more effficiently in a range of conditions.
The company has raised $101m to date, most recently securing $33m from BASF Venture Capital, BASF’s corporate venturing unit, as well as Mandala Capital, CMEA Capital, Saints Capital and additional undisclosed investors, in a May 2014 series D round.
BASF…
